Company / PP&E per Share
ENANTA PHARMACEUTICALS INC PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$1.67
FY2025
5-year range
$0.30 / $1.67
FY2021-FY2025
Trend
+7.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has increased for 4 consecutive years, from $0.30 in FY2021 to $1.67 in FY2025.
Based on SEC 10-K filings.
1.67 in FY2025 with a 5-year CAGR of +30.8%.
Improved from $0.57 to $1.67 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +76.3%
- 5-Year CAGR
- +30.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- ENANTA PHARMACEUTICALS INC's pp&e per share has grown for 4 consecutive years.
- In FY2025, pp&e per share increased 7.6% year-over-year.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.67 | +7.6% |
| FY2024 | $1.55 | +170.8% |
| FY2023 | $0.57 | +87.9% |
| FY2022 | $0.31 | +3.0% |
| FY2021 | $0.30 | -32.2% |
| FY2020 | $0.44 | -22.6% |
| FY2019 | $0.56 | +28.6% |
| FY2018 | $0.44 | +3.6% |
| FY2017 | $0.42 | -1.1% |
| FY2016 | $0.43 | +35.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026